Table 1.
Patient demographics.
| Cohort 1 | % | Cohort 2 | % | Cohort 3 | % | |
|---|---|---|---|---|---|---|
| Total | 11 | 16 | 27 | |||
| Age median (y) | 53 | 62 | 64 | |||
| Sex | ||||||
| Male | 8 | 72.7 | 11 | 68.8 | 16 | 59.3 |
| Female | 3 | 27.3 | 5 | 31.3 | 11 | 40.1 |
| Race, n (%) | ||||||
| White | 8 | 72.7 | 12 | 75 | 19 | 70.4 |
| Other | ||||||
| Unavailable | 3 | 27.3 | 4 | 25 | 8 | 29.6 |
| Ethnicity, n (%) | ||||||
| Hispanic | ||||||
| Non-Hispanic | 8 | 72.7 | 12 | 75 | 19 | 70.4 |
| Unavailable | 3 | 27.3 | 4 | 25 | 8 | 29.6 |
| WHO Grade, n (%) | 8 | 12 | 20 | |||
| III | 1 | 8.3 | 2 | 10 | ||
| IV | 7 | 87.5 | 11 | 91.7 | 17 | 85 |
| N/A | 1 | 12.5 | 1 | 5 | ||
| Disease status | ||||||
| Newly diagnosed | 1 | 6 | 16 | |||
| Recurrent | 6 | 3 | 4 | |||
| N/A | 1 | 3 | ||||
| Medications, n (%; from diseased total) | ||||||
| Anticonvulsants (levetiracetam, clonazepam, lacosamide, carbamazepine, lamotrigine) | 5 | 62.5 | 9 | 75 | 10 | 50 |
| Steroids (dexamethasone) | 7 | 87.5 | 5 | 41.7 | 4 | 20 |
| Blood thinner (aspirin, coumadin) | 3 | 25 | 5 | 25 | ||
| Prior radiotherapy | ||||||
| Prior chemotherapy | ||||||
| Clinical trial participant | 3 | 37.5 | 1 | 8.3 | 1 | 5 |